| Clinical Study "Common" Name (formal title) | Number of enrollees | Funding source (pharmaceutical company/National Institutes of Health [NIH]) | Year complete | Primary publication | Full study treatment protocol/patient disposition |
|---|---|---|---|---|---|
|
MEAD (A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema) |
1048 | Allergan (NCT00168389) | 2012 | Boyer DS, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121(10):1904-1914. https://www.aaojournal.org/article/S0161-6420(14)00378-9/fulltext |
|